SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-028567
Filing Date
2021-07-15
Accepted
2021-07-15 21:27:53
Documents
2
Period of Report
2021-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2814
2 EX-24 DOCUMENT attachment1.htm EX-24 5190
  Complete submission text file 0000899243-21-028567.txt   9384
Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Hambleton Julie (Reporting) CIK: 0001578771 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40602 | Film No.: 211093967

Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Issuer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations